Thema
Journal Article
105
Research Support, Non-U.S. Gov't
64
Research Support, N.I.H., Extramural
41
Myostatin
17
Review
17
Biomarkers
15
Duchenne muscular dystrophy
14
Muscular dystrophy
12
Randomized Controlled Trial
11
Clinical Trial, Phase II
9
Dystrophin
9
facioscapulohumeral muscular dystrophy
9
muscular dystrophy
9
Homeodomain Proteins
7
MRI
7
Multicenter Study
7
Transforming Growth Factor beta
7
Activin Receptors, Type II
6
Case Reports
6
EC 2.7.11.30
6
Mstn protein, mouse
6
Neuromuscular disease
6
Research Support, U.S. Gov't, P.H.S.
6
Comment
5
FSHD
5
activin receptor type II-B
5
516MD5WQ24
4
615
4
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
4
Antibodies, Monoclonal, Humanized
4
Biology
4
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
4
DUX4L1 protein, human
4
Domagrozumab
4
Editorial
4
FKRP
4
Facioscapulohumeral muscular dystrophy
4
G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
4
Imaging
4
MSTN protein, human
4
Research Support, U.S. Gov't, Non-P.H.S.
4
bio
4
che
4
domagrozumab
4
dystrophin
4
tec
4
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
3
Clinical Trial, Phase I
3
Clinical trial
3
Convolutional neural network
3
mehr ...